EUVIMEDEUVIMED entdecken
Systematische Übersicht

Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with probiotics

Ener Cagri Dinleyici, Hania Szajewska, Iva Hojsak, Pedro Gutierrez-Castrellón, Alfredo Guarino, Flavia Indrio, Johannes B van Goudoever, Magnus Domellöf, Raanan Shamir, Francesco Savino, Yvan Vandenplas iD, ESPGHAN Special Interest Group on Gut Microbiota and Modification

Journal of Pediatric Gastroenterology and Nutrition · 2026-01 · 82 (1) · 235-251

DOI: 10.1002/jpn3.70068 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 12.05.2025. Verfasst von Ener Cagri Dinleyici und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey. Hauptthemen laut MEDLINE: Probiotics, Gastrointestinal Microbiome, Infant Formula, Dietary Supplements. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This technical review, one of the five developed by the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) Special Interest Group on Gut Microbiota and Modifications (SIG‐GMM), supports the preparation of a paper on the use of biotic‐supplemented formulas, including those containing probiotics. The SIG‐GMM conducted this review of studies published before December 31, 2023, to evaluate the clinical outcomes of administering probiotic‐supplemented infant formulas to healthy infants (0–12 months). Following the review, all 20 members of the SIG‐GMM anonymously assigned scores of 0–9 for each statement related to probiotic‐supplemented infant formula. A score ≥6 indicated agreement with a statement, but a statement was rejected if 75% of the members concurred regarding its rejection. The systematic review included 28 studies on the effects of probiotic‐supplemented infant formulas. The probiotics studied so far showed no difference compared to the control formula in outcomes such as anthropometric data, gastrointestinal symptoms, stool characteristics, allergy, infections, tolerability and safety. The studies varied in terms of probiotic strains, study designs, and intervention durations. The trials, primarily conducted in Western countries, demonstrated that probiotic‐supplemented formulas were well tolerated, with no significant differences in anthropometric parameters and in the growth of infants compared to those fed nonsupplemented formulas in presumed healthy infants. Some evidence suggests potential benefits of probiotic‐supplemented formulas in reducing gastrointestinal and respiratory infections, although the findings were inconsistent. This technical review provides the foundation for recommendations on the use of probiotic‐supplemented infant formulas in healthy infants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsGastrointestinal MicrobiomeInfant FormulaDietary SupplementsHumansInfantInfant, Newborn

Stichwörter der Autor:innen

bioticbreastfeedingformula feedingmicrobiomemicrobiota

Autor:innen und Institutionen

  • Department of Pediatrics, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
  • Department of Paediatrics, The Medical University of Warsaw, Warsaw, Poland.
  • Children's Hospital Zagreb, University of Zagreb Medical School, Zagreb, Croatia.
  • Universidad Juarez del Estado de Durango & International Scientific Council for Probiotics S.C., Mexico City, Mexico.
  • Pediatric Infectious Disease Unit, Department of Maternal and Child Health, University Hospital "Federico II", Naples, Italy.
  • Medical School MedTech University of Salento, Lecce, Italy.

ORCID-Profile: Yvan Vandenplas

Förderung

  • None

Zitieren

APA

Dinleyici, E. C., Szajewska, H., Hojsak, I., Gutierrez-Castrellón, P., Guarino, A., Indrio, F., van Goudoever, J. B., Domellöf, M., Shamir, R., Savino, F., Vandenplas, Y., & ESPGHAN Special Interest Group on Gut Microbiota and Modification (2026). Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with probiotics. Journal of Pediatric Gastroenterology and Nutrition, 82(1), 235-251. https://doi.org/10.1002/jpn3.70068

Vancouver

Dinleyici EC, Szajewska H, Hojsak I, Gutierrez-Castrellón P, Guarino A, Indrio F, et al. Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with probiotics. Journal of Pediatric Gastroenterology and Nutrition. 2026;82(1):235-251. doi:10.1002/jpn3.70068

BibTeX
@article{Dinleyici2026,
  author = {Dinleyici, Ener Cagri and Szajewska, Hania and Hojsak, Iva and Gutierrez-Castrellón, Pedro and Guarino, Alfredo and Indrio, Flavia and van Goudoever, Johannes B and Domellöf, Magnus and Shamir, Raanan and Savino, Francesco and Vandenplas, Yvan and ESPGHAN Special Interest Group on Gut Microbiota and Modification, ESPGHAN Special Interest Group on Gut Microbiota and Modification},
  title = {Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with probiotics},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2026},
  volume = {82},
  number = {1},
  pages = {235--251},
  doi = {10.1002/jpn3.70068}
}
Kostenlos starten →